Biotoxtech Co. Mutual Funds

Health Care & Life Sciences » Biotechnology | Biotoxtech Co. Ltd.

Biotoxtech Co. Ltd. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

DFA Emerging Markets Core Equity Portfolio

73,776

0.51%

56,129

04/30/2018

DFA Emerging Markets Small Cap Series

59,773

0.41%

13,902

0.01%

01/31/2018

DFA TA World (ex-US) Core Equity Portfolio

2,122

0.02%

04/30/2018

View Profile

Address	Ochang Science Industrial Complex Cheongju-si NC 28115 Korea, Republic Of
Employees	-
Website	http://www.biotoxtech.com
Updated	09/14/2018
Biotoxtech Co., Ltd. engages in the provision of non-clinical drugs trials. It operates through the following business divisions: Safety Evaluation Research Field, Efficacy Evaluation and Analysis Research Field. The Safety Evaluation Research Field offers studies such as general toxicity, local toxicity, reproductive and developmental, genotoxicity, immunotoxicity, carcinogenicity, safety pharmacology, ecotoxicology, histopathology or hematology.